Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Anna Bawden in Malaga

Weight-loss jabs could halve risk of obesity-related cancers, study finds

A Saxenda weight-loss pen
Drugs such as liraglutide (trade name Saxenda) were used in the trial. Photograph: Mohammed_Al_Ali/Shutterstock

Weight-loss jabs could almost halve the risk of obesity-related cancers, a landmark study suggests.

Cancer experts said the findings were “transformational” and could herald a “whole new era of preventive cancer medicine”.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.